Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 5.60%112.15B | 2.54%462.87B | 6.97%121.08B | 1.62%122.16B | 1.17%113.43B | 0.29%106.2B | 10.59%451.41B | 6.92%113.19B | 15.77%120.21B | -43.52%112.12B |
Cost of revenue | 0.48%66.92B | 4.11%291.78B | 9.03%79.4B | 2.12%75.19B | 2.30%70.53B | 2.65%66.6B | 10.58%280.27B | 7.62%72.82B | 14.53%73.62B | -43.26%68.94B |
Gross profit | 14.22%45.23B | -0.03%171.08B | 3.25%41.68B | 0.82%46.97B | -0.63%42.9B | -3.45%39.6B | 10.60%171.14B | 5.67%40.37B | 17.80%46.59B | -43.92%43.18B |
Operating expense | 10.07%36.04B | 13.98%142.08B | 15.97%38.31B | 14.27%36.77B | 15.52%34.1B | 9.39%32.74B | 18.27%124.66B | 12.03%33.03B | 16.18%32.18B | -38.78%29.52B |
Selling and administrative expenses | 9.28%35.98B | 9.70%137.43B | 7.79%35.82B | 6.89%34.5B | 14.72%34.11B | 9.64%32.93B | 12.14%125.27B | 10.68%33.24B | 14.47%32.27B | -44.41%29.73B |
-General and administrative expense | 9.28%35.98B | 9.70%137.43B | 7.79%35.82B | 6.89%34.5B | 14.72%34.11B | 9.64%32.93B | 12.14%125.27B | 10.68%33.24B | 14.47%32.27B | -44.41%29.73B |
Other operating expenses | 365.17%414M | 340.89%6.12B | 486.06%2.9B | 530.23%2.5B | 73.08%540M | -51.63%89M | 11.12%1.39B | -8.16%495M | 194.07%397M | -45.83%312M |
Total other operating income | 30.11%363M | -26.72%1.47B | -40.32%416M | -53.56%228M | 4.37%549M | -3.79%279M | -73.46%2.01B | -35.52%697M | -22.06%491M | -91.00%526M |
Operating profit | 34.01%9.19B | -37.62%29B | -54.05%3.37B | -29.21%10.2B | -35.55%8.8B | -38.11%6.86B | -5.78%46.48B | -15.83%7.33B | 21.58%14.41B | -52.53%13.66B |
Net non-operating interest income (expenses) | 32.70%4.22B | 112.17%8.63B | 250.18%4.8B | 7.86%-2.47B | -19.71%3.13B | 113.57%3.18B | 10.24%4.07B | -44.09%1.37B | -596.30%-2.69B | 457.59%3.89B |
Non-operating interest income | 32.66%4.37B | 103.86%9.19B | 237.45%4.95B | 18.53%614M | -18.79%3.25B | 104.92%3.29B | -22.15%4.51B | -42.46%1.47B | -18.55%518M | 44.77%4B |
Non-operating interest expense | 31.53%146M | 27.21%561M | 53.68%146M | -3.59%3.09B | 13.51%126M | -5.13%111M | -79.02%441M | -1.04%95M | 3,271.58%3.2B | -94.63%111M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | 33.59%13.41B | -25.56%37.63B | -6.15%8.17B | -34.10%7.73B | -32.04%11.93B | -20.15%10.04B | -4.67%50.55B | -22.04%8.7B | -5.40%11.72B | -40.45%17.55B |
Income tax | 20.56%3.96B | -36.55%7.85B | -256.28%-858M | -22.93%1.96B | -35.09%3.46B | -16.78%3.29B | -21.01%12.38B | -85.67%549M | -32.40%2.55B | -33.96%5.33B |
Net income | 39.93%9.45B | -22.01%29.78B | 10.68%9.03B | -37.21%5.76B | -30.70%8.47B | -21.70%6.75B | 2.18%38.18B | 11.22%8.16B | 6.41%9.18B | -42.90%12.22B |
Net income continuous operations | 39.93%9.45B | -22.01%29.78B | 10.68%9.03B | -37.21%5.76B | -30.70%8.47B | -21.70%6.75B | 2.18%38.18B | 11.22%8.16B | 6.41%9.18B | -42.90%12.22B |
Noncontrolling interests | -3.45%28M | 2,333.33%134M | 547.83%103M | 52.17%-11M | 18.18%13M | 0.00%29M | -106.52%-6M | -135.38%-23M | -141.82%-23M | 139.29%11M |
Net income attributable to the company | 40.13%9.42B | -22.37%29.64B | 9.10%8.92B | -37.24%5.77B | -30.76%8.46B | -21.78%6.72B | 2.46%38.18B | 12.57%8.18B | 7.39%9.2B | -43.03%12.21B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 40.13%9.42B | -22.37%29.64B | 9.10%8.92B | -37.24%5.77B | -30.76%8.46B | -21.78%6.72B | 2.46%38.18B | 12.57%8.18B | 7.39%9.2B | -43.03%12.21B |
Gross dividend payment | ||||||||||
Basic earnings per share | 44.17%19.05 | -21.09%58.56 | 11.19%17.72 | -36.18%11.4033 | -29.58%16.7 | -20.85%13.2133 | 3.62%74.2133 | 12.60%15.9367 | 7.59%17.8667 | -41.92%23.7133 |
Diluted earnings per share | 44.17%19.05 | -21.09%58.56 | 11.19%17.72 | -36.18%11.4033 | -29.58%16.7 | -20.85%13.2133 | 3.62%74.2133 | 12.87%15.9367 | 7.59%17.8667 | -41.92%23.7133 |
Dividend per share | 0 | 12.12%24.6667 | 12.12%12.3333 | 0 | 12.12%12.3333 | 0 | 0.00%22 | 0.00%11 | 0 | 0.00%11 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |